Your browser doesn't support javascript.
loading
Integration of "Omics" Strategies for Biomarkers Discovery and for the Elucidation of Molecular Mechanisms Underlying Brugada Syndrome.
Scumaci, Domenica; Oliva, Antonio; Concolino, Antonio; Curcio, Antonio; Fiumara, Claudia Vincenza; Tammè, Laura; Campuzano, Oscar; Pascali, Vincenzo L; Coll, Monica; Iglesias, Anna; Berne, Paola; Casu, Gavino; Olivo, Erika; Ausania, Francesco; Ricci, Pietrantonio; Indolfi, Ciro; Brugada, Josep; Brugada, Ramon; Cuda, Giovanni.
Afiliação
  • Scumaci D; Laboratory of Proteomics, Research Center of Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100, Catanzaro, Italy.
  • Oliva A; Fondazione Policlinico A. Gemelli IRCCS, Roma, Università Cattolica del Sacro Cuore, Large Francesco Vito 1, 00168, Rome, Italy.
  • Concolino A; Laboratory of Proteomics, Research Center of Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100, Catanzaro, Italy.
  • Curcio A; Division of Cardiology, Department of Medical and Surgical Science, University "Magna Graecia" of Catanzaro, 88100, Catanzaro, Italy.
  • Fiumara CV; Laboratory of Proteomics, Research Center of Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100, Catanzaro, Italy.
  • Tammè L; Laboratory of Proteomics, Research Center of Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100, Catanzaro, Italy.
  • Campuzano O; Cardiovascular Genetics Center, Gencardio Institut d'Investigacions Biomèdiques de Girona,, 17290, Girona, Spain.
  • Pascali VL; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV) 17007, Girona, Spain.
  • Coll M; Department of Medical Sciences, School of Medicine, University of Girona, 17004, Girona, Spain.
  • Iglesias A; Fondazione Policlinico A. Gemelli IRCCS, Roma, Università Cattolica del Sacro Cuore, Large Francesco Vito 1, 00168, Rome, Italy.
  • Berne P; Cardiovascular Genetics Center, Gencardio Institut d'Investigacions Biomèdiques de Girona,, 17290, Girona, Spain.
  • Casu G; Cardiovascular Genetics Center, Gencardio Institut d'Investigacions Biomèdiques de Girona,, 17290, Girona, Spain.
  • Olivo E; Unità Operativa Complessa di Cardiologia Ospedale "San Francesco", 08100, Nuoro, Italy.
  • Ausania F; Unità Operativa Complessa di Cardiologia Ospedale "San Francesco", 08100, Nuoro, Italy.
  • Ricci P; Laboratory of Proteomics, Research Center of Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, 88100, Catanzaro, Italy.
  • Indolfi C; Fondazione Policlinico A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Roma.
  • Brugada J; Department of Medical Sciences, School of Medicine, University of Girona, 17004, Girona, Spain.
  • Brugada R; Institute of Legal Medicine, University "Magna Graecia" of Catanzaro, 88100, Catanzaro, Italy.
  • Cuda G; Division of Cardiology, Department of Medical and Surgical Science, University "Magna Graecia" of Catanzaro, 88100, Catanzaro, Italy.
Proteomics Clin Appl ; 12(6): e1800065, 2018 11.
Article em En | MEDLINE | ID: mdl-29956481
PURPOSE: The Brugada syndrome (BrS) is a severe inherited cardiac disorder. Given the high genetic and phenotypic heterogeneity of this disease, three different "omics" approaches are integrated in a synergic way to elucidate the molecular mechanisms underlying the pathophysiology of BrS as well as for identifying reliable diagnostic/prognostic markers. EXPERIMENTAL DESIGN: The profiling of plasma Proteome and MiRNome is perfomed in a cohort of Brugada patients that were preliminary subjected to genomic analysis to assess a peculiar gene mutation profile. RESULTS: The integrated analysis of "omics" data unveiled a cooperative activity of mutated genes, deregulated miRNAs and proteins in orchestrating transcriptional and post-translational events that are critical determining factors for the development of the Brugada pattern. CONCLUSIONS AND CLINICAL RELEVANCE: This study provides the basis to shed light on the specific molecular fingerprints underlying BrS development and to gain further insights on the pathogenesis of this life-threatening cardiac disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Sanguíneas / Biomarcadores / Proteoma / Síndrome de Brugada Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Sanguíneas / Biomarcadores / Proteoma / Síndrome de Brugada Idioma: En Ano de publicação: 2018 Tipo de documento: Article